Tempus Pixel vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Tempus Pixel
VS
by iHealthScreen

AI Verdict

Tempus Pixel is an AI-powered platform for multi-modality medical imaging analysis, enhancing diagnostic accuracy across cardiology, oncology, and neurology. In contrast, iPredict Eye Screening is an AI-powered screening tool specifically for retinal diseases (AMD, DR, Glaucoma) that also provides risk prediction for systemic conditions like stroke and heart attack based on retinal analysis. While both utilize AI in healthcare and address some overlapping disease areas, their core functionalities, data sources, and primary clinical applications are distinct.

Choose Tempus Pixel if…

Choose Tempus Pixel if your institution requires an advanced, multi-modality AI platform for enhancing diagnostic accuracy and workflow efficiency in complex medical imaging across cardiology, oncology, and neurology. This tool is ideal for radiologists and specialists needing sophisticated 3D visualization, quantitative analysis, and automated reporting for MRI, CT, X-ray, and ultrasound scans.

View Tempus Pixel →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your primary care clinic or telemedicine service needs a fast, easy-to-operate AI-powered solution for early detection and screening of age-related macular degeneration, diabetic retinopathy, and glaucoma. This tool is also well-suited for integrating systemic disease risk prediction (stroke, heart attack) into routine patient screenings, providing quick results in non-specialized settings.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus Pixel iPredict Eye Screening
Pricing Unknown Contact for pricing
Deployment Cloud-based Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iPredict Eye Screening

iPredict Eye Screening emphasizes ease of operation, non-invasiveness, and a fast, touchscreen-based workflow, making it highly accessible for primary care settings and quick screening. Tempus Pixel, while web-based and collaborative, focuses on advanced diagnostic features like 3D visualization which may imply a more specialized user experience.

Clinical Value

Tempus Pixel

Tempus Pixel offers broad diagnostic enhancement across multiple modalities (MRI, CT, X-ray, ultrasound) and specialties (cardiology, oncology, neurology), providing advanced AI-powered and quantitative analysis for complex cases. iPredict Eye Screening, while valuable for early detection of specific retinal and systemic diseases, has a more focused screening application.

Pricing & Value

iPredict Eye Screening

iPredict Eye Screening provides a transparent per-patient SaaS pricing model with an estimated cost range and links it to Medicare/commercial payor reimbursement, offering clear insight into its financial value. Tempus Pixel only states 'contact for quote,' which lacks pricing transparency.

Enterprise Readiness

Tempus Pixel

Tempus Pixel, from Tempus (a larger, more established company), explicitly integrates with critical enterprise imaging systems like PACS, EHR, and RIS, indicating robust compatibility with existing hospital infrastructure. Both are HIPAA compliant and FDA cleared, but Tool A's broader integration capabilities suggest greater enterprise readiness.

Innovation

iPredict Eye Screening

While both utilize AI, iPredict Eye Screening demonstrates significant innovation by not only screening for multiple retinal diseases but also predicting systemic disease risks like stroke and heart attack from retinal images, extending its utility into broader preventative health. Tempus Pixel's innovation lies in its multi-modality diagnostic enhancement and collaboration features.

Support & Docs

Tempus Pixel

Tempus Pixel provides a comprehensive 'Document Library' on the Tempus website, including detailed solutions, clinical report guides, requisition forms, and system requirements, indicating extensive and organized support documentation. While iHealthScreen offers product information and publications, a similarly detailed and centralized support documentation hub is not as evident.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus Pixel iPredict Eye Screening
Name Tempus Pixel iPredict Eye Screening
Company Tempus (formerly Arterys) iHealthScreen
Primary Purpose AI-powered, cloud-based medical imaging analysis platform that enhances diagnostic accuracy and workflow efficiency. AI-powered screening tool for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma, with risk prediction for systemic diseases.
Tagline The future of precision medicine that only human + AI can achieve. AI-powered screening tools for early detection of retinal and systemic diseases.
Medical Specialties Cardiology, Oncology, Radiology Family Medicine, Internal Medicine, Ophthalmology
Key AI Focus AI-powered analysis, automated reporting, 3D visualization, quantitative analysis, multi-modality support. AI-Based Screening for DR, AMD, and Glaucoma; AI-Based Telemedicine Service; Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients.

Videos

Demos, reviews, and walkthroughs featuring Tempus Pixel and iPredict Eye Screening.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus Pixel is an AI-powered medical imaging analysis platform designed for radiologists and clinicians across cardiology, oncology, and neurology, enhancing diagnostic accuracy and workflow efficiency. iPredict Eye Screening, on the other hand, offers AI-powered screening for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma, along with risk prediction for systemic diseases like stroke and heart attack, primarily serving Family Medicine, Internal Medicine, and Ophthalmology specialties.
Tempus Pixel offers multi-modality support for MRI, CT, X-ray, and ultrasound, and is DICOM compatible. iPredict Eye Screening primarily utilizes retinal images for screening and analysis of retinal vessels, pathology, and OCT, and also uses data for its online health risk prediction system.
Tempus Pixel provides AI-powered analysis and automated reporting, but specific timeframes for results are not explicitly stated in the provided information. iPredict Eye Screening boasts fast results, with tests completed in less than 5 minutes and reports generated in under 60 seconds.
Tempus Pixel's key features include real-time collaboration, 3D visualization, and quantitative analysis across multiple imaging modalities for complex diagnostic cases. iPredict Eye Screening uniquely offers AI-based telemedicine services, an online health risk prediction system for stroke and heart attack, and an advanced touchscreen interface for ease of operation, along with high accuracy for AMD screening.
AI Tool Finder
AI-powered search. Results may not be comprehensive.